India has decided to temporarily halt the export of Oxford-AstraZeneca’s new type of corona virus (Covid-19) vaccine, due to the need for the use of vaccines within the country due to increasing cases.
According to the news in the BBC, officials from the Indian Ministry of Foreign Affairs reported that the export of the Oxford-AstraZeneca vaccine produced by the Indian Serum Institute to other countries was temporarily suspended after the increase in Covid-19 cases in the country.
Authorities stated that vaccines are needed for domestic use due to increasing cases.
It was stated that this situation may cause some delays in the delivery of vaccines to other countries until the end of April.
According to the statement made by the Ministry of Health of India, 47 thousand 262 new cases have been found in the last 24 hours.
With the death of 275 more people in the last 24 hours, the number of people who died due to the virus increased to 160 thousand 441.
On the other hand, the “Double mutant” variant of Covid-19 was detected in the western states of India.
“ASTRAZENECA VACCINE SAFE”